Lauermann; Vit
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lauermann; Vit.The latest application filed is for "inhibitor which is deactivatable by a reagent produced by a target cell".
- Lauermann; Vit - Belmont CA US
- Lauermann; Vit - Baltimore MD
| Patent | Date |
|---|---|
| Method of site specific activation of an antibody by a protease Grant 9,775,913 - Lauermann October 3, 2 | 2017-10-03 |
| Inhibitor which is deactivatable by a reagent produced by a target cell App 20150314014 - Lauermann; Vit | 2015-11-05 |
| Inhibitor which is deactivatable by a reagent produced by a target cell Grant 8,809,504 - Lauermann August 19, 2 | 2014-08-19 |
| Targeted release App 20040259768 - Lauermann, Vit | 2004-12-23 |
| Retrovirus and viral vectors Grant 6,635,472 - Lauermann October 21, 2 | 2003-10-21 |
| NCAGE Code | 4DR34 | LAUERMANN VIT |
| CAGE Code | 4DR34 | LAUERMANN, VIT |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 